Inovio Eyes Expanded Asian Opportunities, Presence Via Korea Dual Listing
Keen Investor Interest In Country's Bioventure Sector
Executive Summary
Inovio is poised to become the first US-listed company to dual-list in South Korea, as CEO tells Scrip it is seeking to increase its presence and find new opportunities in Asia, while benefiting from strong investor interest in the country’s "very exciting" and vibrant biotech industry.